news Archives - Page 58 of 100 - Journal for Clinical Studies

Current Edition

news

FDA approves Prometic’s inter-alpha-inhibitor-proteins

Rare Pediatric Disease Designation granted for the treatment of patients with necrotizing enterocolitis (NEC) Prometic Life Sciences Inc. announced that the U.S Food ...

7 March 2018 news | North America

Continue Reading →

Europe

Bavarian Nordic Announces Additional Positive Data from a Phase 2 Study of its Universal RSV Vaccine

Presence of antibodies in nasal mucosa suggest vaccine-induced immune protection at source of infection IgA antibodies against RSV observed in both serum and m...

6 March 2018 Europe | news

Continue Reading →

Europe

Medicalchain announces partnership with The Groves Medical Group

The pilot partnership will be open to over 30,000 patients Medicalchain, the decentralised blockchain platform that enables secure, fast and transparent exchange of ...

6 March 2018 Europe | news

Continue Reading →

Europe

Ora, Inc. Unifies its Clinical Environment with Veeva to Accelerate Trial Execution

Fast-growing CRO adopts Veeva Vault Clinical Suite to drive greater efficiency and visibility across global studies Veeva Systems (NYSE: VEEV), today announced that ...

6 March 2018 Europe | news

Continue Reading →

Europe

Therapeutic application of mAbs will increase in near future, says GlobalData

Ever since the first commercial monoclonal antibody (mAb) was approved in 1986 for human therapeutic purposes, mAbs have been increasingly used in several areas of he...

6 March 2018 Europe | news

Continue Reading →

news

Magnetic nanoparticles will help stop internal bleeding 15 times more effectively

Scientists from ITMO University, Project 5-100 participant, have found a new way to effectively stop internal bleeding, one of the most frequent causes of deaths in ...

28 February 2018 news | Russia/Eastern Europe

Continue Reading →

Australasia

New research looks to reduce side effects in commonly used drugs

New research from The Australian National University (ANU) has drilled down to the molecular level to find similarities across six pharmaceutical drugs used in pain r...

28 February 2018 Australasia | news

Continue Reading →

Asia Pacific

Kyowa Kirin and Ultragenyx Announce Crysvita® (burosumab) Receives Conditional Marketing Authorisation in Europe for the Treatment of X–Linked Hypophosphatemia in Children

Kyowa Hakko Kirin Co. Ltd, (Kyowa Hakko Kirin), Kyowa Kirin International PLC (Kyowa Kirin International) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE: Ultragenyx...

27 February 2018 Asia Pacific | Europe | news

Continue Reading →

Europe

LifeArc announces £5M support for rare disease research

LifeArc®, the medical research charity, today announced its Philanthropic Fund will award £5M in grants to support medical research projects focused on rare diseases....

27 February 2018 Europe | news

Continue Reading →

Europe

Domain Therapeutics grants Bristol-Myers Squibb non-exclusive license for G protein-coupled receptor bioSens-All™ technology

Technology provides access to new generation of sensitive biosensors to enhance drug discovery Domain Therapeutics, a France- and Quebec-based biopharmaceutical compa...

27 February 2018 Europe | news

Continue Reading →